+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Rivaroxaban to treat thrombotic antiphospholipid syndrome

Rivaroxaban to treat thrombotic antiphospholipid syndrome

Lancet. Haematology 3(9): E403-E404

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058782311

Download citation: RISBibTeXText

PMID: 27570085

DOI: 10.1016/s2352-3026(16)30107-7

Related references

Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Lupus 24(10): 1087-1094, 2015

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome. Dr. Hannah Cohen about the results of the RAPS trial (Lancet Haematol 2016; 3: e426-36). Rheumatology 56(9): E23-E23, 2017

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial. Lancet. Haematology 3(9): E426-E436, 2016

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. Journal of Thrombosis and Haemostasis 13(7): 1264-1273, 2015

Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases. Clinical Rheumatology 35(3): 801-805, 2016

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial. Lupus 25(3): 301-306, 2016

How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review. Blood 110(9): 3122-3127, 2007

Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?. Clinical and Experimental Rheumatology 15(5): 541-544, 1997

Paediatric case report: primary antiphospholipid syndrome presented with non-thrombotic neurological picture psychosis; treat by antidepressants alone?. International Journal of Rheumatic Diseases 12(2): 170-173, 2009

Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis and Rheumatism 64(2): 504-512, 2012

Rituximab action on the antiphospholipid antibodies in patients with thrombotic antiphospholipid syndrome. Medicina Clinica 146(12): E69-E70, 2016

AB0726The utility of IGA antiphospholipid antibodies for prediction of thrombotic complications in secondary antiphospholipid syndrome. Annals of the Rheumatic Diseases 71(Suppl 3): 680.3-680, 2013

Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment. Current Pharmaceutical Design 22(28): 4451-4469, 2016

Prevention of thrombotic recurrences after an initial thrombotic event in antiphospholipid syndrome A retrospective study. Lupus 5(5): 557, 1996

Transient disappearance of serum antiphospholipid antibodies during the course of a thrombotic event in two adolescents with antiphospholipid syndrome receiving prednisone. Clinical and Experimental Rheumatology 12(4): 460-461, 1994